跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Klindex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Klindex
Approved
STANDARD
Klindex
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
acfe0cba40f59e6d
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
acfe0cba40f59e6d
Drug Approval Philippines Name
Klindex
Product Name
Klindex
Registration Number
DRP-2640-03
Brand Name
Klindex
Generic Name
Clindamycin (As Hydrochloride)
Dosage Form
Capsule
Dosage Strength
300 mg
Manufacturer
Amherst Laboratories, Inc.
Trader
UNILAB, Inc.
Issuance Date
28 April 2022
Expiry Date
25 May 2027
Pharmacologic Category
Antibacterial (Lincosamide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
acfe0cba40f59e6d
Type
Standard
Back to Philippines FDA Approvals